Recombinant single-chain Fv antibody fragment-alkaline phosphatase conjugate: A novel in vitro tool to estimate rabies viral glycoprotein antigen in vaccine manufacture

Journal of Virological Methods

Volumn 146, Issue 1-2, 2007, Pages 246-256

  Mousli, Mohamed ^a   Turki, Imène ^a   Kharmachi, Habib ^a   Saadi, Mohamed ^a   Dellagi, Koussay ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

Author keywords

Alkaline phosphatase; Immunoenzymatic conjugates; Potency assay; Rabies virus; Recombinant protein; scFv

Indexed keywords

50AD1 MONOCLONAL ANTIBODY; ANTIBODY CONJUGATE; DNA FRAGMENT; GLYCOPROTEIN; MONOCLONAL ANTIBODY; RABIES VACCINE; RECOMBINANT SINGLE CHAIN FV ANTIBODY FRAGMENT ALKALINE PHOSPHATASE CONJUGATE; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOT HYBRIDIZATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; IMMUNODETECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RABIES VIRUS; SENSITIVITY AND SPECIFICITY; TECHNOLOGY;

ALKALINE PHOSPHATASE; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; BASE SEQUENCE; CELL LINE; IMMUNOASSAY; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR SEQUENCE DATA; RABIES; RABIES VACCINES; RABIES VIRUS; RECOMBINANT FUSION PROTEINS; VIRAL ENVELOPE PROTEINS;

BACTERIA (MICROORGANISMS); PROKARYOTA; RABIES VIRUS;

EID: 35648985047     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.07.015     Document Type: Article

References (53)

1. Avrameas S. Enzyme immunoassays and related techniques: development and limitations. Curr. Top. Microbiol. Immunol. 104 (1983) 93-99
2. Avrameas S. Amplification systems in immunoenzymatic techniques. J. Immunol. Methods 150 (1992) 23-32
3. Barth R., Diderrich G., and Weinmann E. NIH test, a problematic method for testing potency of inactivated rabies vaccine. Vaccine 6 (1988) 369-377
4. Billiald P., Mousli M., Goyffon M., and Vaux D. Engineering of a bioluminescent antigen-binding protein. Biotechnol. Lett. 19 (1997) 1037-1041
5. Blancou J., Aubert M.F., Cain E., Selve M., Thraenhart O., and Bruckner L. Effect of strain differences on the potency testing of rabies vaccines in mice. J. Biol. Stand. 17 (1989) 259-266
6. Boulain J.C., and Ducancel F. Expression of recombinant alkaline phosphatase conjugates in Escherichia coli. Methods Mol. Biol. 267 (2004) 101-112
7. Carrier A., Ducancel F., Settiawan N.B., Cattolico L., Maillere B., Leonetti M., Drevet P., Menez A., and Boulain J.C. Recombinant antibody-alkaline phosphatase conjugates for diagnosis of human IgGs: application to anti-HBsAg detection. J. Immunol. Methods 181 (1995) 177-186
8. Casey J.L., Coley A.M., Tilley L.M., and Foley M. Green fluorescent antibodies: novel in vitro tools. Protein Eng. 13 (2000) 445-452
9. Cox J.H., Dietzschold B., and Schneider L.G. Rabies virus glycoprotein. II. Biological and serological characterization. Infect. Immun. 16 (1977) 754-759
10. Ducancel F., Gillet D., Carrier A., Lajeunesse E., Menez A., and Boulain J.C. Recombinant colorimetric antibodies: construction and characterization of a bifunctional F(ab)2/alkaline phosphatase conjugate produced in Escherichia coli. Biotechnology 11 (1993) 601-605
11. European Pharmacopoeia, 1985. Vaccinum rabiei inactivatum ad usum veterinarium. In: Monograph European Pharmacopoeia, part II/9, 2nd ed., p. 451.
12. Ferguson M., and Heath A. Report of a collaborative study to assess the determination of glycoprotein antigen content of rabies vaccines for human use. Biologicals 20 (1992) 143-154
13. Flamand A., Raux H., Gaudin Y., and Ruigrok R.W. Mechanisms of rabies virus neutralization. Virology 194 (1993) 302-313
14. Fournier-Caruana J., Poirier B., Haond G., Jallet C., Fuchs F., Tordo N., and Perrin P. Inactivated rabies vaccine control and release: use of an ELISA method. Biologicals 31 (2003) 9-16
15. Gamoh K., Senda M., Itoh O., Muramatsu M., Hirayama N., Koike R., Endoh Y.S., and Minamoto N. Use of ELISA for in vitro potency test of rabies vaccines for animal use. Biologicals 24 (1996) 95-101
16. Gamoh K., Shimazaki Y., Senda M., Makie H., Itoh O., Muramatsu M., Hirayama N., and Hatakeyama H. Establishment of a potency test by ELISA for a rabies vaccine for animal use in Japan. J. Vet. Med. Sci. 65 (2003) 685-688
17. Gaudin Y., Tuffereau C., Durrer P., Flamand A., and Ruigrok R.W. Biological function of the low-pH, fusion-inactive conformation of rabies virus glycoprotein (G): G is transported in a fusion-inactive state-like conformation. J. Virol. 69 (1995) 5528-5534
18. Gillet D., Ducancel F., Pradel E., Leonetti M., Menez A., and Boulain J.C. Insertion of a disulfide-containing neurotoxin into E. coli alkaline phosphatase: the hybrid retains both biological activities. Protein Eng. 5 (1992) 273-278
19. Hankins D.G., and Rosekrans J.A. Overview, prevention, and treatment of rabies. Mayo Clin. Proc. 79 (2004) 671-676
20. Horton R.M., Hunt H.D., Ho S.N., Pullen J.K., and Pease L.R. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77 (1989) 61-68
21. Huang D., and Shusta E.V. A yeast platform for the production of single-chain antibody-green fluorescent protein fusions. Appl. Environ. Microbiol. 72 (2006) 7748-7759
22. Kabat, E.A., Wu, T.T., Perry, H., Gottesman, K., Foeller, C., 1991. Sequences of Proteins of Immunological Interest, NIH Publication No. 91-3242, 5th ed.
23. Kerschbaumer R.J., Hirschl S., Kaufmann A., Ibl M., Koenig R., and Himmler G. Single-chain Fv fusion proteins suitable as coating and detecting reagents in a double antibody sandwich enzyme-linked immunosorbent assay. Anal. Biochem. 249 (1997) 219-227
24. Kirsch M., Zaman M., Meier D., Dubel S., and Hust M. Parameters affecting the display of antibodies on phage. J. Immunol. Methods 301 (2005) 173-185
25. Lafon M., Perrin P., Versmisse P., and Sureau P. Use of a monoclonal antibody for quantitation of rabies vaccine glycoprotein by enzyme immunoassay. J. Biol. Stand. 13 (1985) 295-301
26. Lindbladh C., Mosbach K., and Bulow L. Use of genetically prepared enzyme conjugates in enzyme immunoassay. Trends Biochem. Sci. 18 (1993) 279-283
27. Merienne K., Germain N., Zinn-Justin S., Boulain J.C., Ducancel F., and Menez A. The functional architecture of an acetylcholine receptor-mimicking antibody. J. Biol. Chem. 272 (1997) 23775-23783
28. Mousli M., Goyffon M., and Billiald P. Production and characterization of a bivalent single chain Fv/alkaline phosphatase conjugate specific for the hemocyanin of the scorpion Androctonus australis. Biochim. Biophys. Acta 1425 (1998) 348-360
29. Mousli M., Devaux C., Rochat H., Goyffon M., and Billiald P. A recombinant single-chain antibody fragment that neutralizes toxin II from the venom of the scorpion Androctonus australis hector. FEBS Lett. 442 (1999) 183-188
30. Mousli, M., Turki I., Kharmachi, H., Dellagi, K., 2007. Genetically engineered colorimetric single-chain antibody fusion protein for rapid diagnosis of rabies virus. In: Second OIE/WHO/EU International Conference on Rabies: Towards the Elimination of Rabies in Eurasia, Paris, France. Submit in the symposia series, Dev. Biol. (Basel).
31. Muller B.H., Lamoure C., Le Du M.H., Cattolico L., Lajeunesse E., Lemaitre F., Pearson A., Ducancel F., Menez A., and Boulain J.C. Improving Escherichia coli alkaline phosphatase efficacy by additional mutations inside and outside the catalytic pocket. Chem. Biochem. 2 (2001) 517-523
32. Nagarajan T., Reddy G.S., Mohana Subramanian B., Rajalakshmi S., Thiagarajan D., Tordo N., Jallet C., and Srinivasan V.A. A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture. Biologicals 34 (2006) 21-27
33. Nilson B.H., Logdberg L., Kastern W., Bjorck L., and Akerstrom B. Purification of antibodies using protein L-binding framework structures in the light chain variable domain. J. Immunol. Methods 164 (1993) 33-40
34. Orlandi R., Gussow D.H., Jones P.T., and Winter G. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 3833-3837
35. Perrin P., Morgeaux S., and Sureau P. In vitro rabies vaccine potency appraisal by ELISA: advantages of the immunocapture method with a neutralizing anti-glycoprotein monoclonal antibody. Biologicals 18 (1990) 321-330
36. Perrin P. Techniques for the preparation of rabies conjugates. In: Meslin F.X., Kaplan M., and Koprowski H. (Eds). Laboratory Techniques in Rabies (1996), World Health Organization, Geneva, Switzerland 433-445
37. Porstmann T., and Kiessig S.T. Enzyme immunoassay techniques. An overview. J. Immunol. Methods 150 (1992) 5-21
38. Rau D., Kramer K., and Hock B. Single-chain Fv antibody-alkaline phosphatase fusion proteins produced by one-step cloning as rapid detection tools for ELISA. J. Immunoassay Immunochem. 23 (2002) 129-143
39. Raux H., Coulon P., Lafay F., and Flamand A. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing. Virology 210 (1995) 400-408
40. Rooijakkers E.J., Uittenbogaard J.P., Groen J., and Osterhaus A.D. Rabies vaccine potency control: comparison of ELISA systems for antigenicity testing. J. Virol. Methods 58 (1996) 111-119
41. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning: A Laboratory Manual. 2nd ed. (1989), Cold Spring Harbor Laboratory Press, New York
42. Schwalbach G., Sibler A.P., Choulier L., Deryckere F., and Weiss E. Production of fluorescent single-chain antibody fragments in Escherichia coli. Protein Exp. Purif. 18 (2000) 121-132
43. Seligmann Jr. E.B. The NIH test for potency. In: Kaplan M.M., and Koprowski H. (Eds). Laboratory Techniques in Rabies. 3rd ed. (1973), World Health Organization, Geneva 279-286
44. Skerra A., and Pluckthun A. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 240 (1988) 1038-1041
45. Sureau P. Rabies vaccine production in animal cell cultures. Advances in Biochemical Engineering, Biotechnology vol. 34 (1987), Springer, Berlin, Heidelberg pp. 111-128
46. Takazawa T., Kamiya N., Ueda H., and Nagamune T. Enzymatic labeling of a single chain variable fragment of an antibody with alkaline phosphatase by microbial transglutaminase. Biotechnol. Bioeng. 86 (2004) 399-404
47. Uhlen M., and Moks T. Gene fusions for purpose of expression: an introduction. Methods Enzymol. 185 (1990) 129-143
48. Wels W., Harwerth I.M., Zwickl M., Hardman N., Groner B., and Hynes N.E. Construction, bacterial expression and characterization of a bifunctional single-chain antibody-phosphatase fusion protein targeted to the human erbB-2 receptor. Biotechnology 10 (1992) 1128-1132
49. Wiktor T.J., Gyorgy E., Schlumberger D., Sokol F., and Koprowski H. Antigenic properties of rabies virus components. J. Immunol. 110 (1973) 269-276
50. World Health Organisation. In: Meslin F.X., Kaplan M.M., and Koprowski H. (Eds). Laboratory Techniques in Rabies. 4th ed. (1996), WHO, Geneva, Switzerland
51. World Health Organisation, 1992. WHO Expert Committee on Rabies, 8th report. WHO Technical Report Series, vol. 824, pp. l-84.
52. Wunner W.H., Dietzschold B., Curtis P.J., and Wiktor T.J. Rabies subunit vaccines. J. Gen. Virol. 64 (1983) 1649-1656
53. Zhou H., Fisher R.J., and Papas T.S. Optimization of primer sequences for mouse scFv repertoire display library construction. Nucleic Acids Res. 22 (1994) 888-889